Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy
Small · 2025
DOI: 10.1002/smll.202406839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Yang Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Hospital of Dalian University of Technology, Dalian University of Technology, Shenyang, 110042, China. Hauptthemen laut MEDLINE: Glioblastoma, Immunotherapy, Tumor-Associated Macrophages, Brain Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Xingliao Talent Plan Project, "Oncology+" Open project of Liaoning Cancer Hospital.
Abstract (Originalsprache)
Glioblastoma (GBM), the most malignant brain tumor with high prevalence, remains highly resistant to the existing immunotherapies due to the significant immunosuppression within tumor microenvironment (TME), predominantly manipulated by M2‐phenotypic tumor‐associated macrophages (M2‐TAMs). Here in this work, an M2‐TAMs targeted nano‐reprogrammers, MG5‐S‐IMDQ, is established by decorating the mannose molecule as the targeting moiety as well as the toll‐like receptor (TLR) 7/8 agonist, imidazoquinoline (IMDQ) on the dendrimeric nanoscaffold. MG5‐S‐IMDQ demonstrated an excellent capacity of penetrating the blood‐brain barrier (BBB) as well as selectively targeting M2‐TAMs in the GBM microenvironment, leading to a phenotype transformation and function restoration of TAMs shown as heightened phagocytic activity toward tumor cells, enhanced cytotoxic effects, and improved tumor antigen cross‐presentation capability. In the meantime, by induction of a function‐oriented “gear effect”, MG5‐S‐IMDQ treatment extended its impact systemically by enhancing the infiltration of type I conventional dendritic cells (cDC1s) into the tumor sites and bolstering adaptive immune responses. In sum, by precisely working on M2‐TAMs as a unique target in tumor situ, the nano‐reprogrammers successfully established a robust immune network that worked synergistically to combat tumors. This facile nanoplatform‐based immunomodulatory strategy, serving as a powerful and convenient immune monotherapy or as a complementary treatment alongside other therapies like surgery, provided deep insights for advancing translational study in GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Hospital of Dalian University of Technology, Dalian University of Technology, Shenyang, 110042, China.
- State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.
- State Key Laboratory of Fine Chemicals, Department of Pharmacy, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.
ORCID-Profile: Kun Shao
Förderung
- National Natural Science Foundation of China
- Liaoning Xingliao Talent Plan Project
- "Oncology+" Open project of Liaoning Cancer Hospital
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, Y., Li, G., Su, J., Liu, Y., Zhang, X., Zhang, G., Wu, Z., Li, J., Wang, X., Zhang, Y., Bai, M., Yao, Y., Wang, R., & Shao, K. (2025). Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy. Small. https://doi.org/10.1002/smll.202406839
Vancouver
Wang Y, Li G, Su J, Liu Y, Zhang X, Zhang G, et al. Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy. Small. 2025. doi:10.1002/smll.202406839
BibTeX
@article{Wang2025,
author = {Wang, Yang and Li, Guangzhe and Su, Jianlong and Liu, Yiming and Zhang, Xiaomai and Zhang, Guanyi and Wu, Zhihao and Li, Jinrong and Wang, Xu and Zhang, Yuxuan and Bai, Mingrui and Yao, Yuanhang and Wang, Ruimin and Shao, Kun},
title = {Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202406839}
}
EUVIMED